Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis... por Strand, V, Sebba, A, Scardo, S, Quebe, A, Zaremba-Pechmann, L, Taylor, P, Sholter, D

Long-term efficacy of baricitinib in patients with rheumatoid arthritis who have had inadequate response to csDMARDs: results from ra-beyond up to 7 years of treatment por Caporali, R, Aletaha, D, Sanmarti, R, Takeuchi, T, Mo, D, Haladyj, E, Zaremba-Pechmann, L, Taylor, PC

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study por Caporali, R, Taylor, PC, Aletaha, D, Sanmartí, R, Takeuchi, T, Mo, D, Haladyj, E, Bello, N, Zaremba-Pechmann, L, Fang, Y, Dougados, M